BSE Live
Dec 29, 16:01Prev. Close
2192.10
Open Price
2194.15
Bid Price (Qty.)
2175.00 (8)
Offer Price (Qty.)
2181.90 (5)
NSE Live
Dec 29, 15:52Prev. Close
2193.00
Open Price
2200.60
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
2182.00 (225)
| Key Financial Ratios of Mankind Pharma (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 10 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 201.50 | 171.85 | 145.07 | 106.69 | 115.94 | |
| Diluted EPS (Rs.) | 201.50 | 171.85 | 145.07 | 106.69 | 115.94 | |
| Cash EPS (Rs.) | 219.30 | 185.10 | 156.95 | 112.42 | 118.94 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 977.89 | 776.61 | 604.76 | 459.68 | 336.89 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 977.89 | 776.61 | 604.76 | 459.68 | 336.89 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 3.50 | |
| Revenue from Operations/Share (Rs.) | 1,344.66 | 1,142.61 | 984.44 | 824.08 | 731.82 | |
| PBDIT/Share (Rs.) | 297.28 | 256.41 | 210.51 | 145.31 | 172.15 | |
| PBIT/Share (Rs.) | 279.49 | 243.15 | 198.63 | 139.58 | 169.16 | |
| PBT/Share (Rs.) | 278.75 | 242.43 | 197.93 | 138.91 | 168.14 | |
| Net Profit/Share (Rs.) | 201.50 | 171.85 | 145.07 | 106.69 | 115.94 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 22.10 | 22.44 | 21.38 | 17.63 | 23.52 | |
| PBIT Margin (%) | 20.78 | 21.28 | 20.17 | 16.93 | 23.11 | |
| PBT Margin (%) | 20.72 | 21.21 | 20.10 | 16.85 | 22.97 | |
| Net Profit Margin (%) | 14.98 | 15.03 | 14.73 | 12.94 | 15.84 | |
| Return on Networth / Equity (%) | 20.60 | 22.12 | 23.98 | 23.20 | 34.41 | |
| Return on Capital Employed (%) | 28.09 | 30.69 | 32.06 | 29.45 | 49.63 | |
| Return on Assets (%) | 14.58 | 15.78 | 16.31 | 15.00 | 23.28 | |
| Total Debt/Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | |
| Asset Turnover Ratio (%) | 1.09 | 1.16 | 1.23 | 0.00 | 1.73 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 2.40 | 2.71 | 2.32 | 2.19 | 2.10 | |
| Quick Ratio (X) | 1.84 | 2.15 | 1.74 | 1.43 | 1.44 | |
| Inventory Turnover Ratio (X) | 0.39 | 0.35 | 0.24 | 0.00 | 0.22 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 3.01 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 2.94 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 96.99 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 97.06 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 96.98 | |
| Price/BV (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
12.11.2025
Mankind Pharma Standalone September 2025 Net Sales at Rs 2,608.78 crore, up 3.12% Y-o-Y
11.11.2025
07.11.2025
Mankind Pharma Consolidated September 2025 Net Sales at Rs 3,697.16 crore, up 20.17% Y-o-Y
07.11.2025
12.11.2025
Mankind Pharma Standalone September 2025 Net Sales at Rs 2,608.78 crore, up 3.12% Y-o-Y
07.11.2025
Mankind Pharma Consolidated September 2025 Net Sales at Rs 3,697.16 crore, up 20.17% Y-o-Y
01.08.2025
Mankind Pharma Consolidated June 2025 Net Sales at Rs 3,570.35 crore, up 23.4% Y-o-Y
01.08.2025
Mankind Pharma Standalone June 2025 Net Sales at Rs 2,541.36 crore, up 5.75% Y-o-Y